
Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses the role pharmacists can play when helping clinicians overcome barriers to initiating insulin use.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses the role pharmacists can play when helping clinicians overcome barriers to initiating insulin use.

Both exercise and calorie restriction have additive beneficial effects.


Ranibizumab (Lucentis), a prescription drug frequently used to treat age-related vision loss, can also improve vision in patients with diabetic retinopathy and diabetic macular edema, a recent study indicated.

Type 2 diabetes drugs could lead to complications that cause hospitalization.

The advantages offered by insulin pens may help improve patient adherence.

In patients at risk for type 2 diabetes, diet and exercise have beneficial effects on regulating glucose levels beyond those associated with weight loss.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses some barriers clinicians may face to initiating insulin use.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses how pharmacists can help their patients who take insulin.

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP, professor of pharmacy practice at MCPHS University, discusses some barriers patients may have to starting insulin.

Taking statins associated with greater likelihood of developing diabetes with complications.

Even healthy adults taking statins are 87% more likely to develop diabetes.

Although metformin can help prevent diabetes onset in those at high risk, the medication is rarely prescribed for this purpose.

Gene may help identify clue to separation of overactive and underactive immune activity.

Novel pathway regulating immune cell movement may help eliminate debilitating effects of several serious diseases.

Meter can test glucose levels within 5 seconds.

Jennifer Costello, PharmD, BCPS, BC-ADM, ambulatory care clinical pharmacist in the Internal Medicine Faculty Practice at Saint Barnabas Medical Center in Livingston, New Jersey, talks about the benefits and risks of insulin therapy.

Jennifer Costello, PharmD, BCPS, BC-ADM, ambulatory care clinical pharmacist in the Internal Medicine Faculty Practice at Saint Barnabas Medical Center in Livingston, New Jersey, describes some ways in which pharmacists can help patients with type 2 diabetes mellitus manage their disease.

Women with a history of depression may have greater odds of developing gestational diabetes.

Record number of orphan drugs approved in 2014.

Abbott's new blood glucose meter is now widely available OTC without insurance co-pays.

Treatments found to improve glycemic control.

Treatment found to lower blood sugar levels in obese mice.

The lack of generic insulin may keep patients from using the medicine, even though they risk life-threatening complications, new research from Johns Hopkins University School of Medicine suggests.

An FDA advisory panel recommends adding a warning about the potential risk for heart failure to the labels of saxagliptin (Onglyza), saxagliptin/metformin (Kombiglyze), and alogliptin (Nesina).